Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
SLP Stock Forecast 2026-2027
$16.32
Current Price
$329.75M
Market Cap
Buy 2
Hold 4
Sell 0
Wall St Analyst Ratings
Distance to SLP Price Targets
+90.0%
To High Target of $31.00
+44.0%
To Median Target of $23.50
-2.0%
To Low Target of $16.00
SLP Price Momentum
+2.8%
1 Week Change
+20.3%
1 Month Change
-14.4%
1 Year Change
-10.5%
Year-to-Date Change
-31.4%
From 52W High of $23.80
+47.2%
From 52W Low of $11.09
📊 TOP ANALYST CALLS
Did SLP Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Simulations Plus is one of their latest high-conviction picks.
Latest SLP Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, SLP has a neutral consensus with a median price target of $23.50 (ranging from $16.00 to $31.00). The overall analyst rating is Buy (7.3/10). Currently trading at $16.32, the median forecast implies a 44.0% upside. This outlook is supported by 2 Buy, 4 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Brendan Smith at TD Cowen, suggesting a 2.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SLP Analyst Ratings
2
Buy
4
Hold
0
Sell
SLP Price Target Range
Low
$16.00
Average
$23.50
High
$31.00
Current: $16.32
Latest SLP Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SLP.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 10, 2026 | TD Cowen | Brendan Smith | Hold | Maintains | $16.00 |
| Jan 8, 2026 | TD Cowen | Hold | Maintains | $N/A | |
| Dec 18, 2025 | BTIG | Neutral | Downgrade | $N/A | |
| Sep 30, 2025 | TD Cowen | Hold | Initiates | $N/A | |
| Jul 15, 2025 | Stephens & Co. | Overweight | Maintains | $N/A | |
| Jul 15, 2025 | Keybanc | Sector Weight | Downgrade | $N/A | |
| Jul 14, 2025 | Keybanc | Overweight | Maintains | $N/A | |
| Jul 7, 2025 | BTIG | Buy | Maintains | $N/A | |
| Jun 18, 2025 | JMP Securities | Market Perform | Reiterates | $N/A | |
| Jun 13, 2025 | Craig-Hallum | Buy | Maintains | $N/A | |
| Apr 16, 2025 | Keybanc | Overweight | Maintains | $N/A | |
| Jan 24, 2025 | Keybanc | Overweight | Maintains | $N/A | |
| Jan 8, 2025 | Keybanc | Overweight | Maintains | $N/A | |
| Nov 15, 2024 | Stephens & Co. | Overweight | Initiates | $N/A | |
| Nov 6, 2024 | William Blair | Outperform | Reiterates | $N/A | |
| Oct 24, 2024 | William Blair | Outperform | Reiterates | $N/A | |
| Oct 24, 2024 | BTIG | Buy | Maintains | $N/A | |
| Sep 12, 2024 | William Blair | Outperform | Reiterates | $N/A | |
| Jul 29, 2024 | Keybanc | Overweight | Initiates | $N/A | |
| Jul 16, 2024 | JMP Securities | Market Perform | Initiates | $N/A |
Simulations Plus, Inc. (SLP) Competitors
The following stocks are similar to Simulations Plus based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
SLP
Simulations Plus
mkt cap
320.86M
Simulations Plus, Inc. (SLP) Financial Data
Simulations Plus, Inc. has a market capitalization of $329.75M with a P/E ratio of 48.5x. The company generates $80.54M in trailing twelve-month revenue with a -78.0% profit margin.
Revenue growth is +8.3% quarter-over-quarter, while maintaining an operating margin of +23.2% and return on equity of -38.8%.
Valuation Metrics
Market Cap
$329.75M
Enterprise Value
$288.43M
P/E Ratio
48.5x
PEG Ratio
1.0x
Price/Sales
4.1x
Growth & Margins
Revenue Growth (YoY)
+8.3%
Gross Margin
+66.5%
Operating Margin
+23.2%
Net Margin
-78.0%
EPS Growth
+47.5%
Financial Health
Cash/Price Ratio
+12.7%
Current Ratio
5.5x
Debt/Equity
0.4x
ROE
-38.8%
ROA
+3.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Simulations Plus, Inc. (SLP) Business Model
About Simulations Plus, Inc.
What They Do
Provides modeling and simulation software for biopharma.
Business Model
Simulations Plus generates revenue through the sale of its advanced modeling and simulation software, as well as through consulting services tailored to the pharmaceutical and biotechnology industries. Their tools facilitate drug discovery, development, and regulatory processes, enabling clients to enhance R&D efficiency and make informed decisions.
Additional Information
Founded in 1996 and based in Lancaster, California, Simulations Plus serves a diverse range of clients, including major pharmaceutical and biotech companies, demonstrating a strong market presence. The company is focused on accelerating model-informed drug development, which positions it well in the growing biopharma sector.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
212
CEO
Country
United States
IPO Year
1997
Website
www.simulations-plus.comSimulations Plus, Inc. (SLP) Latest News & Analysis
Latest News
Quick Summary
Johnson Fistel, PLLP is investigating potential securities law violations by Simulations Plus, Inc. (NASDAQ: SLP), focusing on misleading statements about financial outlook and reporting practices.
Why It Matters
The investigation into Simulations Plus for potential securities law violations raises concerns about financial transparency, which could impact stock performance and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) for potential securities law violations related to misleading statements about its financial outlook and internal controls.
Why It Matters
The investigation into Simulations Plus for potential securities law violations raises concerns about its financial integrity, which could impact stock value and investor confidence.
Source: Newsfile Corp
Market Sentiment:
Neutral
Quick Summary
Robbins LLP is investigating Simulation Plus, Inc. (NASDAQ: SLP) for potential securities law violations and fiduciary breaches by its officers and directors.
Why It Matters
Robbins LLP's investigation into Simulation Plus for potential securities law violations may signal regulatory risks and governance issues, impacting investor confidence and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of federal securities laws by the company or its executives.
Why It Matters
The investigation into Simulations Plus for potential securities law violations could impact its stock price and investor confidence, leading to increased volatility and potential legal repercussions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) for potential federal securities law violations after the company lowered its 2025 revenue outlook and reported an auditor dispute.
Why It Matters
Simulations Plus faces potential legal issues and financial instability, which can lead to stock price volatility and increased risk for shareholders, impacting investment decisions.
Source: Newsfile Corp
Market Sentiment:
Neutral
Quick Summary
Robbins LLP is investigating Simulation Plus, Inc. (NASDAQ: SLP) for potential violations of securities laws and breaches of fiduciary duties by its officers and directors.
Why It Matters
The investigation into Simulation Plus for potential securities law violations could lead to legal repercussions, affecting stock performance and investor confidence in the company.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About SLP Stock
What is Simulations Plus, Inc.'s (SLP) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Simulations Plus, Inc. (SLP) has a median price target of $23.50. The highest price target is $31.00 and the lowest is $16.00.
Is SLP stock a good investment in 2026?
According to current analyst ratings, SLP has 2 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $16.32. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SLP stock?
Wall Street analysts predict SLP stock could reach $23.50 in the next 12 months. This represents a 44.0% increase from the current price of $16.32. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Simulations Plus, Inc.'s business model?
Simulations Plus generates revenue through the sale of its advanced modeling and simulation software, as well as through consulting services tailored to the pharmaceutical and biotechnology industries. Their tools facilitate drug discovery, development, and regulatory processes, enabling clients to enhance R&D efficiency and make informed decisions.
What is the highest forecasted price for SLP Simulations Plus, Inc.?
The highest price target for SLP is $31.00 from at , which represents a 90.0% increase from the current price of $16.32.
What is the lowest forecasted price for SLP Simulations Plus, Inc.?
The lowest price target for SLP is $16.00 from Brendan Smith at TD Cowen, which represents a -2.0% decrease from the current price of $16.32.
What is the overall SLP consensus from analysts for Simulations Plus, Inc.?
The overall analyst consensus for SLP is neutral. Out of 2 Wall Street analysts, 2 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $23.50.
How accurate are SLP stock price projections?
Stock price projections, including those for Simulations Plus, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 13, 2026 2:44 PM UTC